Morphinofobia: the situation among the general population and health care professionals in North-Eastern Portugal by Henk Verloo et al.
Verloo et al. BMC Palliative Care 2010, 9:15
http://www.biomedcentral.com/1472-684X/9/15
Open AccessR E S E A R C H  A R T I C L EResearch articleMorphinofobia: the situation among the general 
population and health care professionals in 
North-Eastern Portugal
Henk Verloo*1, Emmanuel K Mpinga2, Maria Ferreira3, Charles-Henri Rapin4 and Philippe Chastonay5
Abstract
Background: Morphinofobia among the general population (GP) and among health care professionals (HP) is not 
without danger for the patients: it may lead to the inappropriate management of debilitating pain. The aim of our 
study was to explore among GP and HP the representation and attitudes concerning the use of morphine in health 
care.
Methods: A cross-sectional study was done among 412 HP (physicians and nurses) of the 4 hospitals and 10 
community health centers of Beira Interior (Portugal)and among 193 persons of the GP randomly selected in public 
places. Opinions were collected through a translated self-administered questionnaire.
Results: A significant difference of opinion exists among GP and HP about the use of morphine. The word morphine 
first suggests drug to GP (36,2%) and analgesia to HP (32,9%.). The reasons for not using morphine most frequently 
cited are: for GP morphine use means advanced disease (56%), risk of addiction (50%), legal requirements (49,7%); for 
HP it means legal risks (56,3%) and adverse side effects of morphine such as somnolence - sedation (30,5%) The socio-
demographic situation was correlated with the opinions about the use of morphine.
Conclusions: False beliefs about the use of morphine exist among the studied groups. There seems to be a need for 
developing information campaigns on pain management and the use of morphine targeting. Better training and more 
information of HP might also be needed.
Background
During the last decades, considerable progress has been
recorded in the knowledge of the action and the use of
opiates in pain management [1-3]. In spite of this prog-
ress, the pain prevalence in general populations and
health care institutions remains high, varying from 20 to
80% depending on the region or the country [4-7].
Why has this knowledge not been applied by HP and
did not have the expected effects among the GP? Do mor-
phine frighten so much the GP and HP becoming a public
health problem?
Morphinofobia can be defined as a set of false beliefs
concerning the negative effects of morphine in the man-
agement of pain [8], an inappropriate attitude of profes-
sionals in the pain management due to a lack of
knowledge [9], a philosophical opposition to the pre-
scription and the use of morphine in pain management
[10].
Morphinofobia seems widespread and caused by igno-
rance, prejudices, false beliefs, economic marketing strat-
egies and limitations in the availability of morphine [8,10-
16].
In 1960, the studies of Robins et al. [17] and Abeles et
al. [18] reported false beliefs of health professionals in the
use of morphine: it was related to fears of addiction and
abuse, to limited information on legal aspects, a lack of
knowledge about the use of opiates by health profession-
als (physicians) and users (patients) and to the negative
image of morphine in general. Similar observations have
been reported in a recent study by Zacny et al. [19]: mor-
phine was often associated with advanced disease, immi-
nent death, illicit drug addiction, euthanasia, potential
risks of abuse, excessive sedation and fear of pursuit by
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Page 2 of 9authorities [5,7,10,14,20-25]. Few studies compared atti-
tudes and perceptions related to the use of morphine as
an analgesic among GP and HP in a given region.
Musi et al. [26] studied the myths of morphine in the
Valley of Aosta in Northern Italy interrogating 380 health
professionals and the general population about their fears
in using morphine. They showed that despite the avail-
ability of morphine, its low costs and its efficacy, the pre-
scription and the acceptance of opioïdes, and more
specifically of morphine, in health care institutions was
low.
Our study aims to compare morphinofobia among the
general population (GP) and health professionals (physi-
cians and nurses) (HP) in a country where the consump-
tion of morphine was multiplied by 4 over the last decade
[27], though its prescription is tightly regulated by public
health authorities [28].
Methods
The survey was carried out between August and Novem-
ber 2005 using two structured questionnaires, developed
based on the model of Musi et al. [26]. One of the authors
(MF) translated the questionnaires in Portuguese and
later conducted the survey. After a translation check by
two Portuguese health professionals the questionnaires
were pilot-tested among 5 GP and 5 HP in the province of
Beira Interior.
Data Collection
The GP was recruited randomly on a given day in two
shopping centres, three urban restaurants, the weekly
marketplace and at the railroad station of Guarda. The
participation criteria were: at least 18 years old, able to
answer the questionnaire and living in the region of Beira
Interior.
As to the GP, a questionnaire was addressed to 800 HP
(nurses and physicians) employed at four hospitals of
Beira Interior (hospitals of Cova da Beira, Fundão,
Guarda and Castélo Branco) and ten community care
centres (Belmonte, Castélo Branco, Covilhã, Fundão,
Idanha-A_Nova, Oleiros, Penamacor, Provença-a- Nova,
Sertã, Vila Velha of Rodão) with the agreement of the
regional Department of Health of Beira Interior.
The HP were working in internal medicine, general sur-
gery, paediatrics, oncology, orthopaedics, emergency and
community home care. The participation criteria were:
be employed in one of the hospitals or community home
care centres for at least a year and having a completed
training as a nurse or as a physician.
The questionnaires were distributed via the manage-
ment of the institutions and answers were returned by the
same channel under ceiled envelope. The inquiry was
anonymous. The study was approved by the Research
Ethics Committee of the University Institute of Kurt
Bösch Sion, Switzerland.
Research Instrument
For each group, we developed a specific questionnaire
based on the study of Musi et al. [26].
The first part of each questionnaire addresses socio-
demographic data. The second part of the questionnaire
addresses the perception people have of "morphine", its
efficacy and its side effects. The questionnaire also
explores the attitudes concerning the use of morphine
and its acceptance. A judgment scale of 5 levels, ranging
from "completely disagree" to "completely agree" was
used.
Data was analyzed with « Khi 2of Pearson », « t-test for
matched samples » and « correlation of Pearson » using
the software program SPSS version 15.0. Significant dif-
ferences (p-value) between categories or groups of vari-
ables were defined at 95%.
Results




194 persons of GP answered the questionnaire. One
questionnaire was discarded. About six out of ten respon-
dents were women. Age range was between 18 and 80
years. About 20% of the respondents had not been to
school and about 30% had only attended primary school.
Almost half of the interviewed people lived in urban
areas. A vast majority of respondents (87%) were Catho-
lics (Table 1). The demographic profile of our so-called
GP roughly corresponds to the demographic distribution
of the population of the region Beira Interior, except for
gender, yet the studied sample must be considered as an
opportunistic sample.
Health Professionals (HP)
Of 700 questionnaires addressed to nurses and 100 to
physicians, 412 were returned. The sample included 366
nurses (89%) and 46 physicians (11%). The participation
rate of nurses was 52,3% the physicians' 46,0%. On the
average the participation rate was 51,5%. Three quarters
of the respondents were women. The average age was
35,5 years. About 70% of the respondents lived in semi-
urban areas. The majority of the HP (93%) were Catholics
(Table 1). The sample roughly represents the doctors/
nurses rate in health care in Portugal. Non-respondents
were not specifically characterized in our study, but were
globally not different from the respondents (same sex
ratio, age distribution, religion, and years of professional
experience).
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Perception of the word « Morphine »
Significant differences exist between GP and HP in their
perception of the word "morphine". For HP the word
"morphine" first stands for « analgesic » (32,9% ), whereas
for GP it first means «drugs» (36,2%). Other differences
exist between GP and HP, such as «medication» (15,9%
versus 5,2%,), "sedation- somnolence» (9,1% - 0,5%), «can-
cer» (0% versus 14,9%), «dependency» (0% versus 1,8%,)
«opiate» (6,9% versus 15,9%), «relief» (0% versus 16,4%).
Some similarities also exist, such as «pain-suffering» (GP
1,7% versus HP4,1%) and «end of life - death» ( GP 2,3%
versus HP 2,8%). One third of GP « does not know » what
morphine stands for. The results are summarized in Table
2.
Opinions about the use of morphine as an analgesic
The opinions among GP and HP concerning the use of
morphine as an analgesic appear in Table 3.
GP shows more false beliefs than HP concerning the
use of morphine as an analgesic. The largest difference
exists for «it means that it is serious» (46,8%; p = 0,000),
Table 1: Characteristics of the GP and HP
Variables GP n (%) HP n (%) P- Value
Sex of respondents (GP n = 176-H P n = 412)
Male 82 (42) 108 (26,2) 0,000*
Female 111 (58) 304 (73,8)
Age of respondents (GP n = 174 -H P n = 396)
18-25 years 27 (15,5) 82(19,9)
26-65 years 102 (58,6) 313(76,0) 0,000*
>65 44 (25,9) 1 (0,2)
No response 3 16
Level of training (GP n = 176 -H P n = 412)
Without schooling 36 (20,5)
Only primary 50 (28,4)
Secondary school 46 (26,1) 0,000*
High school 20 (11,4) 366 (88,8)
High school 20 (11,4) 366 (88,8)
University 24 (13,6) 46 (11,2)
No response 18 -
Place of living (GP n = 176 - HP n = 409)
Rural 78 (44,3) 123 (24,4)
Urban 98 (55,6) 284 (75,6) 0,001*
Other - 5
No response 17 -
Religion (GP n = 175 - HP n = 408)
Catholic 152 (86,9) 385 (93,4)
Jewish 1 (0,6) 2 (0,5)
Jehovah 22 (12,6) 2 (0,5) 0,000*
Protestant - 7 (1,7)
Other 16 (3,9)
No response 18 -
* Significant difference P-value ≤ 0.05
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(13%; p = 0,002.)
Relationship between socio- demographic features and the 
perceptions of the use of morphine as an analgesic
Table 4 presents a matrix of the correlation coefficients of
Pearson between socio-demographic features and opin-
ions on the use of morphine as an analgesic.
Data analysis shows an absence of a significant relation-
ship between the sex of the respondents and the ques-
tions «risks of delirium» (r = 0.041; p = 0,330), «diminish
the surviving period» (r = 0,051; p = 0,223), «risks of
increasing doses» (r = 0,058; p = 0,166) and «the legal
risks» (r = 0,025; p = 0,543). A weak negative relationship
was seen between sex and the expressions «it means that
it is serious» (r = 0,134; p = 0,001), «risks of dependency»
(r = 0,094; p = 0,024), «risks of somnolence» (r = 0,110; p =
0,008) «limited life expectancy» (r = 0,125; p = 0,003) and
«risks of discrimination» (r = 0,096; p = 0,023). Men are
less prone to consider and use morphine as an analgesic
than women.
A positive weak relationship was observed between the
age of the respondents and the perceptions of the use of
morphine. The older the respondents, the more false
beliefs exist about the use of morphine.
A weak negative relationship between level of training
of the respondents and the variable «legal risks» (r =
0,106; p = 0,011) was observed. A weak positive relation-
ship was observed between place of living and the
expressions «it means that it is serious» (r = 0,134; p =
0,001), «risks of dependency» (r = 0,119; p = 0,004),
«diminish surviving period» (r = 0,145; p = 0,000), «lim-
ited life expectancy» (r = 0,147; p = 0,000) and «risk of dis-
crimination» (r = 0,169; p = 0,000). No relationship was
noticed with the variables «risk of delirium» (r = 0,053; p
= 0,207), «risks of somnolence» (r = 0,025; p = 0,547),
«risks of accustom» (r = 0,032; p = 0,441) and "legal risks»
(r = 0,034; p = 0,412).
Discussion
This study compared the use of morphine as perceived by
GP and HP in the region of Beira Interior in North-East-
ern Portugal. There are differences of perception but also
common fears. It might well induce some reluctance
regarding the use of morphine. This in turn might influ-
ence negatively patient care in general and pain manage-
ment more specifically.
Most studies reporting "false beliefs" regarding the use
of morphine in pain management focus either on specific
Table 2: Perception of the word « morphine » among the GP and HP (only one answer possible)
GENERAL POPULATION n = 176 (%) HEALTH 
PROFESSIONELS
n = 412 (%) P-VALUE
Drug 63 (35,7) Analgesic 128 (32,9)
Don't know 57 (32,3) Relief 64 (16,5)
Medication 28 (15,9) Opiate 62 (15,9)
Sedation- somnolence 16 (9,1) Cancer 58 (14,9)
Opiate 12 (6,8) Drug 43 (11,1)
Analgesic 11 (6.2) Medication 20 (5,2) 0,000 *
End-of-Life - Death 4 (2,3) Pain-Suffering 16 (4,1)




* Significant difference p- value ≤ 0.05
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Studies comparing GP and HP in this field are few. One
done by Musi et al. [26] in Northern Italy confirms our
results. These authors mention than 39% of GP primarily
associate the word morphine with «drugs» and «the risks
of somnolence, dependency and the seriousness of the
clinical situation». Other studies also support our obser-
vations. Weisse et al. [31] report that the physicians' atti-
tude in prescribing analgesics for pain management
varies according sex and ethnic group. Bernades [32]
reports a difference in perception of pain according to
sex. Riley et al. [29,33] and Robinson et al. [30] show a
significant difference in chronic pain management
according to age.
In our study morphinofobia among HP seems related to
false beliefs on side effects of morphine, risks of addiction
and legal constraints in the prescription of morphine. Yet
the word morphine is principally associated with the
notion of analgesia. Musi et al. [26] reports in his study
among HP that the word morphine is associated first with
« pain » followed by «analgesia, drug, cancer, death and
sedation» which does not differ much from our observa-
tions. Other authors report similar data to ours. Seddon
et al. [34] mention clearly that the use of morphine in
pain management is strongly influenced by the society's
perceptions, especially as far as addiction and the legal
constrains go. The recent Italian study of Bandieri et al.
[13] analysed the consumption of opioids between 2000
and 2008 and showed an increase in the use of opioids in
general, but a decrease use of oral morphine. The conclu-
sions of the authors are clear: the behaviour of physicians
is still largely contrary to guidelines, suggesting that
either cultural or marketing rather than legal factors are
mainly responsible for morphinofobia. Staton [35]
reports a significant difference in the perception of pain
between physicians and patients, especially among cer-
tain ethnic groups (Afro-Americans). Nishimori [36]
studying opiates abuse among patients at home reported
treatment failure by physician in case of opioïde depen-
dency. Ballantyne et al. [37] in a review of literature on
Table 3: Opinions about the use of morphine as an analgesic among the GP and HP
OPINIONS ABOUT USE OF MORPHINE GP AGREEMENT (%) HP AGREEMENT (%) % DIFFERENCE GP - HP P-Value
It means that it is serious (GP n = 171; 
HP n = 399)
96 (56,1) 37 (9,3) 46,8 0,000*
There is a risk to develop dependency 
(GP n = 171; HP n = 405)
70 (41.0) 6 (1,5) 39,5 0,000*
There is a risk of delirium or euphoria 
(GP n = 171; HP n = 405)
68 (39.8) 18 (4,4) 35,4 0,000*
It does diminish the surviving period 
(GP n = 171; HP n = 407)
61 (35,7) 13 (3,2) 32,5 0,002*
There is a risk of somnolence or 
sedation (PG n = 170; PS n = 403)
74 (43,5) 123 (30,5) 13,0 0,000*
It can lead to increasing doses 
(GP n = 170; HP n = 403)
85 (50,0) 105 (26,1) 23,9 0,000*
It is a sign of limited life expectancy 
(GP n = 171 - HP n = 409)
47 (27,5) 4 (1,0) 26,5 0,000*
It increases legal risks in relation to 
other medication (GP n = 171; HP 
n = 407)
85 (49,7) 229 (56,3) -6,6 0,149
There is a risk of discrimination 
(PG n = 169; PS n = 397)
33 (19,5) 10 (2,5) 17,0 0,000*
* Significant difference P value ≤ 0.05
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about the use of morphine as an analgesic
OPINIONS ABOUT USE OF MORPHINE SEX AGE LEVEL OF TRAINING PLACE OF LIVING
Its means that it is serious - Correlation coefficient -0.134** 0.403** -0.375** -0.134**
Sig. (bil.) 0.001 0.000 0.000 0.001
N 570 554 570 568
Risks of developing dependency Correlation coefficient -0.094* 0.481** -0.545** -0.119**
Sig. (bil.) 0.024 0.000 0.000 0.004
N 575 558 575 573
Risks of delirium or euphoria - Correlation coefficient -0.041 0.469** -0.467** -0.053
Sig. (bil.) 0.330 0.000 0.000 0.207
N 576 559 576 574
Diminish surviving period - Correlation coefficient -0.051 0.514** -0.583** -0.145**
Sig. (bil.) 0.223 0.000 0.000 0.000
N 578 561 578 576
Risks of somnolence or sedation - Correlation coefficient -0.110** 0.254** -0.192** 0.025
Sig. (bil) 0.008 0.000 0.000 0.547
N 577 560 577 575
Risks of increasing doses - Correlation coefficient -0.058 0.265** -0.241** -0.032
Sig. (bil.) 0.166 0.000 0.000 0.441
N 573 556 573 571
Limited life expectancy - Correlation coefficient -0.125** 0.474** -0.488** -0.147**
Sig. (bil.) 0.003 0.000 0.000 0.000
N 580 563 580 578
Legal constrains- Correlation coefficient 0.025 0.129** -0.106* -0.034
Sig. (bil.) 0.543 0.002 0.011 0.412
N 578 561 578 576
Risks of discrimination - Correlation coefficient -0.096* 0.278** -0.517** -0.169**
Sig. (bil.) 0.023 0.000 0.000 0.000
N 566 549 566 564
* Significant correlation on 0,05 level (bilateral)** significant correlation on 0,01 level (bilateral)
chronic pain treatment with opioïdes shows discrimina-
tion in prescribing morphine in relation with fears of
dependencies.
Many studies report fears and false beliefs concerning
the use of morphine in pain management among HP
[14,22,38-40]; e.g. Larue et al. [41] report false beliefs of
general practitioners and oncologists in France; negative
attitudes of nurses in the use of morphine in pain man-
agement are reported from Australia [22] from the USA
[23] and from Hong Kong [42].
The existence of false beliefs on pain, addiction and
abuse of morphine have also been reported by Gilson et
al. [21] in a study among 300 American physicians. Fur-
thermore Nwokeji et al. [43] reported that among 267
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partment
andgeneral practitioners who agreed to prescribe opioïdes to
patients suffering from chronic non-cancerous pains, half
feared addiction and abuse. White et al. [44] studying the
attitudes of hospital physicians on opiate prescription,
confirm that opiophobia is often related to fears of
dependency. Devi et al. [45] questioning 253 Malaysian
physicians reported that 83% of the respondents consider
a possible addiction and the fear of exceeding sedation
and respiratory depression as the main obstacles in pre-
scribing morphine. Clinical documented experiences
have proven that these fears are not justified [3,46-49].
Some physicians may also lack knowledge on morphine
pharmacokinetics or may be unfamiliar with morphine
prescription [50]. Ripamonti et al., [16] concluded in an
Italian study of cancer patients that despite the WHO
guidelines and EAPC recommendations, there was an
inappropriate use of transdermal opioids by Italian physi-
cians in situations where the use of oral morphine was
not contraindicated.
Our results showed a rather weak relationship between
socio-demographic features and the perceptions of the
use of morphine in pain management. Yet morphinofobia
was highest among little-educated older men living in
rural areas. The cultural and geographic influences on
attitudes and beliefs regarding morphine among patients
with non cancerous pains have been stressed by Mon-
sivais et al. [51] and Cicero et al. [52]. However a litera-
ture review by Turk [53] is cautious in this regard.
Ripamonti et al., [16] mentioned that patients were hav-
ing a problem in taking morphine but they had no cul-
tural problems with other opioids. Most patients knew
what morphine meant but do not know the role and the
potency of other opioids.
Health professionals play an important role as far as
morphinofobia is concerned, be it through a possible lack
of knowledge regarding morphine [23,54], be it out of
"more philosophical" reasons as suggested by Covington
[10] and Bandieri et al., [13]. Yun et al. [55] and Edwards
et al. [22] therefore suggest the necessity to develop more
positive attitudes among HP regarding the use of mor-
phine.
There are limits to our study. First a generalisation to
the population of Beira Interior of our observations might
not be indicated because of the small sample of GP and
its opportunistic nature. Second, our study focused on
attitudes and perceptions on morphine of GP (potential
patient) and HP and did not take in consideration the
patients' vision. Third, it should be kept in mind that
some of our results are matter of debate in the specialized
literature [25,52]. Last, our study concentrated on the
concept of morphinofobia and should not be generalized
for other opioids.
Conclusion
This study contributes to a better understanding of "the
myths of morphine" among the general population and
health professionals in the region of Beira Interior. It sug-
gests that efficient pain management is not limited to the
prescription of an adequate analgesic according to « the
golden standard ». The success of a morphine prescrip-
tion is influenced by a multitude of other factors.
Our results are in accordance with the results of the
study by Musi et al. [26] done in a similar regional setting.
There seems to be quite a misunderstanding of "mor-
phine" as well among GP as HP in North-Eastern Portu-
gal. Such a misunderstanding might well end up in
straight forward morphinofobia, thus ultimately compro-
mising an appropriate pain management strategy as rec-
ommended by W.H.O. guidelines and EAPC
recommendations.
This leads us to suggest that there is a need for informa-
tion campaigns targeting the general population and for
better training programs targeting health care profession-
als based on the theory of planned clinical behaviour [14]
in order to improve acceptance and efficacy of pain man-
agement.
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